The economic divide and tuberculosis. Tuberculosis is not just a medical problem, but also a problem of social inequality and poverty

EMBO Reports

Volumn 4, Issue SPEC. ISS., 2003, Pages

  van Helden, Paul D ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CAUSE OF DEATH; DISEASE COURSE; ECONOMIC ASPECT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION CONTROL; MIGRATION; PATIENT CARE; PLAGUE; POVERTY; PRIORITY JOURNAL; SIDE EFFECT; SOCIAL STATUS; TUBERCULOSIS; UNEMPLOYMENT; CROWDING (AREA); FOOD INDUSTRY; FOOD SECURITY; GENETIC SUSCEPTIBILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MALNUTRITION; MEDICAL RESEARCH; MYCOBACTERIUM TUBERCULOSIS; POPULATION GROWTH; REVIEW; SOCIAL ASPECT; SOCIAL STRUCTURE; STRESS; SUBSTANCE ABUSE;

ANTITUBERCULAR AGENTS; COSTS AND COST ANALYSIS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; POVERTY; SOCIAL PROBLEMS; TUBERCULOSIS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0038454581     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.embor842     Document Type: Article

References (10)

1. Bond, P. (2002) Unsustainable South Africa. University of Natal Press, Scottsville, South Africa.
2. Daniel, T.M. (1999) Captain of Death: The Story of Tuberculosis. Boydell & Brewer, Rochester, New York, USA.
3. Diamond, J. (1998) Guns, Germs and Steel. Vintage, London.
4. Dubos, R. & Dubos, J. (1992) The White Plague 2nd edn. Ruttgers University Press, New Brunswick, New Jersey, USA.
5. Gandy, M. & Zumla, A. (2002) The resurgence of disease: social and historical perspectives on the 'new' tuberculosis. Soc. Sci. Med., 55, 385-396.
6. Huntington, S.P. (1998) The Clash of Civilizations and the Remaking of World Order. Simon & Schuster, London, UK.
7. Landes, D.S. (1999) The Wealth and Poverty of Nations. Abacus, London.
8. Lillebaek, T. et al. (2002) Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis., 185, 401-404.
9. Lopert, R., Lang, D.L., Hill, S.R. & Henry, D.A. (2002) Differential pricing of drugs: a role for cost-effective analysis? Lancet, 359, 2105-2107.
10. van Helden, P.D. (2002) Molecular epidemiology of TB: challenging dogmas and asking new questions. IUBMB Life, 53, 219-223.